Deena S. Lasheen

Discovery of Potent VEGFR-2 Inhibitors based on Furopyrimidine and Thienopyrimidne Scaffolds as Cancer Targeting Agents

M. Abdel Aziz, Rabah A.T. Serya, Deena S. Lasheen et al. · Scientific Reports · 2016 · 170 citations · Full text

Surmounting the resistance against EGFR inhibitors through the development of thieno[2,3-d]pyrimidine-based dual EGFR/HER2 inhibitors

Sandra N. Milik, Amal Kamal Abdel‐Aziz, Deena S. Lasheen et al. · European Journal of Medicinal Chemistry · 2018 · 68 citations · Full text

Medicinal Chemistry, Medicine, Rational Drug Design +9

Toward discovery of mutant EGFR inhibitors; Design, synthesis and in vitro biological evaluation of potent 4-arylamino-6-ureido and thioureido-quinazoline derivatives

Samar Mowafy, Athanasios Galanis, Zainab M. Doctor et al. · Bioorganic & Medicinal Chemistry · 2016 · 60 citations · Full text

Medicinal Chemistry, Thioureido-quinazoline Derivatives, Mutant Egfr Inhibitors +9

3D-QSAR pharmacophore modelling, virtual screening and docking studies for lead discovery of a novel scaffold for VEGFR 2 inhibitors: Design, synthesis and biological evaluation

Mahitab K. Sobhy, Samar Mowafy, Deena S. Lasheen et al. · Bioorganic Chemistry · 2019 · 52 citations

Medicinal Chemistry, Virtual Screening, Drug Target +10

Click and Release: SO₂ Prodrugs with Tunable Release Rates

Xingyue Ji, Eman M. El‐labbad, Kaili Ji et al. · Organic Letters · 2017 · 45 citations